A. Judd, T. Duong, L. Galli
Nov 25, 2013
Citations
0
Influential Citations
5
Citations
Quality indicators
Journal
Pharmacoepidemiology and Drug Safety
Abstract
Fosamprenavir, combined with low‐dose ritonavir (FPV/r), is indicated for treatment of HIV‐infected children aged ≥6 years in Europe. Our purpose was to assess the safety of licensed use of FPV/r in HIV‐infected children reported to six cohorts in the European Pregnancy and Paediatric HIV Cohort Collaboration.